Keystone Capital Launches Gillson Sciences to Advance Human Health Through Scientific Excellence
Keystone Capital Management has established Gillson Sciences, a new entity aimed at providing comprehensive laboratory testing and advisory solutions to enhance product safety and compliance in the healthcare and environmental sectors.
Keystone Capital Management has announced the formation of Gillson Sciences, a new venture dedicated to offering laboratory testing, monitoring, and advisory services. This initiative is set to provide clients in the pharmaceuticals, biopharma, medical devices, healthcare, and environmental sciences sectors with the necessary tools to ensure product safety, compliance, and regulatory excellence. The creation of Gillson Sciences marks a significant step forward in addressing complex human health challenges through science-driven solutions.
Gillson Sciences emerges from the strategic acquisitions of Azzur Labs and Micro Measurement Laboratories, now rebranded as Gillson Testing. This consolidation brings together two leading experts in their fields, enabling the company to offer more integrated and comprehensive scientific solutions. With laboratories in Pennsylvania, Illinois, and California, and a team of field personnel across the U.S., Gillson Sciences is well-positioned to meet the diverse needs of its clients.
Leading the charge as CEO is Jason Fischer, whose extensive experience at UL Solutions, including roles such as President of Enterprise & Advisory Services and Global Vice President of Corporate Development, equips him with the expertise to steer Gillson Sciences towards becoming a market leader. Fischer's vision for the company emphasizes building a robust platform focused on advancing human health through testing, monitoring, and advisory solutions.
The partnership between Keystone Capital and Jason Fischer underscores a shared commitment to fostering innovation and excellence in the testing, inspection, certification, and compliance (TICC) sector. Todd Lanscioni, Managing Director at Keystone Capital, expressed confidence in Fischer's leadership and the Gillson team's ability to realize their collective vision for the platform.
Gillson Sciences is not only focused on its current offerings but is also actively seeking opportunities to expand its capabilities and reach within the TICC sector. The company's mission revolves around advancing quality, safety, and regulatory excellence, ensuring that it remains at the forefront of addressing critical human health challenges. For more information, visit https://GILLSONSCIENCES.com.